TNFSF10 and prostate carcinoma: Similarly, although mitoxantrone enhances TRAIL-induced apoptosis by upregulating DR4 expression levels in glioblastoma and prostate cancer cells [27,28,29], it did not affect DR4 expression in HT29 cells.